Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karyn L Hamilton

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Nutrients|March 13, 2025
Short-Term Magnesium Supplementation Has Modest Detrimental Effects on Cycle Ergometer Exercise Performance and Skeletal Muscle Mitochondria and Negligible Effects on the Gut Microbiota: A Randomized Crossover Clinical TrialMatthew C Bomar, Taylor R Ewell, Reagan L Brown, et al.
Geroscience|August 8, 2020
Sex differences in changes of protein synthesis with rapamycin treatment are minimized when metformin is added to rapamycinChristopher A Wolff, Marcus M Lawrence, Hunter Porter, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 7, 2014
Greater muscle protein synthesis and mitochondrial biogenesis in males compared with females during sprint interval trainingRebecca L Scalzo, Garrett L Peltonen, Scott E Binns, et al.
The Journal of Nutrition|January 29, 2021
Physiologic Responses to Dietary Sulfur Amino Acid Restriction in Mice Are Influenced by Atf4 Status and Biological SexWilliam O Jonsson, Nicholas S Margolies, Emily T Mirek, et al.
The Journal of Physiology|August 4, 2022
Phytochemical compound PB125 attenuates skeletal muscle mitochondrial dysfunction and impaired proteostasis in a model of musculoskeletal declineRobert V Musci, Kendra M Andrie, Maureen A Walsh, et al.
Aging Cell|June 18, 2016
Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducerRandy Strong, Richard A Miller, Adam Antebi, et al.
Aging Cell|September 30, 2022
Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous miceRandy Strong, Richard A Miller, Catherine J Cheng, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 30, 2019
Commentaries on Viewpoint: Rejuvenation of the term sarcopeniaHenning T Langer, Agata A Mossakowski, Keith Baar, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Nutrients|March 13, 2025
Short-Term Magnesium Supplementation Has Modest Detrimental Effects on Cycle Ergometer Exercise Performance and Skeletal Muscle Mitochondria and Negligible Effects on the Gut Microbiota: A Randomized Crossover Clinical TrialMatthew C Bomar, Taylor R Ewell, Reagan L Brown, et al.
Geroscience|August 8, 2020
Sex differences in changes of protein synthesis with rapamycin treatment are minimized when metformin is added to rapamycinChristopher A Wolff, Marcus M Lawrence, Hunter Porter, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 7, 2014
Greater muscle protein synthesis and mitochondrial biogenesis in males compared with females during sprint interval trainingRebecca L Scalzo, Garrett L Peltonen, Scott E Binns, et al.
The Journal of Nutrition|January 29, 2021
Physiologic Responses to Dietary Sulfur Amino Acid Restriction in Mice Are Influenced by Atf4 Status and Biological SexWilliam O Jonsson, Nicholas S Margolies, Emily T Mirek, et al.
The Journal of Physiology|August 4, 2022
Phytochemical compound PB125 attenuates skeletal muscle mitochondrial dysfunction and impaired proteostasis in a model of musculoskeletal declineRobert V Musci, Kendra M Andrie, Maureen A Walsh, et al.
Aging Cell|June 18, 2016
Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducerRandy Strong, Richard A Miller, Adam Antebi, et al.
Aging Cell|September 30, 2022
Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous miceRandy Strong, Richard A Miller, Catherine J Cheng, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 30, 2019
Commentaries on Viewpoint: Rejuvenation of the term sarcopeniaHenning T Langer, Agata A Mossakowski, Keith Baar, et al.
Pageof 10